SEC Form 4 · accession 0001209191-18-062459
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Davidson
Officer — Chief Medical Officer
Period of report
Dec 11, 2018
Accepted (ET)
Dec 13, 2018 · 4:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $7.96 | Dec 11, 2018 | A | 175,000 | A | — | Dec 10, 2028 | Common Stock | 175,000 | 175,000 | D |
Explanation of responses
- F1This option vests 25% on December 11, 2019 and then in quarterly installments over 3 years thereafter.